Behavioral Intervention

Cognitive Behavioral Therapy + Psychoeducation for Anxiety in Children With Autism

Baltimore, MD

N/A

Recruiting

Research Sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 4 years 0 months to 6 years 11 months

Receptive and expressive language age equivalent > 36 months based on Test of Early Language Development, Fourth Edition (TELD-4)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up before and after 14-week treatment (baseline to post-treatment) and at 4 month follow-up

Awards & highlights

No Placebo-Only Group

Summary

This trial seeks to reduce anxiety & intolerance of uncertainty in autistic children under 7, with few studies on this age range. Cognitive-behavioral therapy (CBT) approaches are being tested to see if they work.

See full description

Who is the study for?

This trial is for young children aged 4 to nearly 7 with autism who also show signs of anxiety. They should not have other neurological or genetic conditions, and must be able to communicate in basic English. A parent must join them for a 14-week online therapy program.Check my eligibility

What is being tested?

The DINO RCT is testing a new telehealth cognitive-behavioral therapy called DINOSAUR, designed specifically for autistic children with anxiety. It aims to reduce their anxiety and intolerance of uncertainty over the course of the study.See study design

What are the potential side effects?

Since this intervention involves behavioral therapy rather than medication, traditional side effects are not expected; however, participants may experience emotional discomfort or increased anxiety initially as they confront anxious feelings during sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 4 and 6 years old.

show original

Select...

My language skills are at or above a 3-year-old level according to the TELD-4 test.

show original

Select...

I have been diagnosed with Autism Spectrum Disorder (ASD) based on clinical assessment and ADOS-2 results.

show original

Select...

I do not have conditions like epilepsy, Down syndrome, or severe vision problems.

show original

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ before and after 14-week treatment (baseline to post-treatment) and at 4 month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~before and after 14-week treatment (baseline to post-treatment) and at 4 month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and before and after 14-week treatment (baseline to post-treatment) and at 4 month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in child anxiety diagnostic status on Anxiety Disorders Interview Schedule, Autism Spectrum Disorder Addendum (ADIS-ASA)

Secondary study objectives

Change in anxiety severity on Child Behavior Checklist

Change in child's intolerance of uncertainty on Response to Uncertainty and Low Environmental Stability Scale

Change on parental accommodating behaviors on Family Accommodation Scale following 14-week active control and 14-week intervention.

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: TreatmentExperimental Treatment1 Intervention

Parent-child dyads will receive DINOSAUR, a group-based cognitive-behavioral therapy (CBT) intervention, adapted for young children and delivered via telehealth. This 14 week intervention teaches parents and children strategies to reduce anxiety and intolerance of uncertainty, an underlying construct of anxiety.

Group II: Active ControlActive Control1 Intervention

Parents in the active control condition will participate in three psychoeducational groups focused on presenting information regarding anxiety prevalence, differentiating anxiety from autism, and anxiety triggers. These groups will be delivered via telehealth across a 14-week period.

0 / 4Eligibility criteria met